1 not yet recruiting, 1 recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Systemic Sclerosis (Scleroderma): new trials by email Literature Review of Systemic Sclerosis (Scleroderma) trials Research Report on Systemic Sclerosis (Scleroderma)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Systemic Sclerosis (SSc) Refractory to Standard Therapy C-CAR168 - Systemic Sclerosis (SSc), Systemic Sclerosis | Phase 1 | Not yet recruiting | AbelZeta Inc. | 12 | 2027-03-01 | 2026-10-13 |
| Cultural Adaptation, Validity, and Reliability of the Turkish Version of The PASTUL Questionnaire Questionnaire study - Systemic Sclerosis (SSc), Systemic Sclerosis (Scleroderma) | Recruiting | Hacettepe University | 50 | 2025-08-04 | 2025-09-19 | |
| Treatment of Early Systemic Sclerosis by Bosentan bosentan - Systemic Sclerosis (Scleroderma) | Phase 1 / Phase 2 | Terminated | Rikshospitalet University Hospital | 30 | 2005-01-01 | 2009-06-12 |
Scleroderma, Diffuse (3) · Scleroderma, Systemic (3) · Autoimmune Diseases (1) · Fibrosis (1)
Connective Tissue Diseases (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Immune System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Bosentan (1)
AbelZeta Inc. (1) · Hacettepe University (1) · Rikshospitalet University Hospital (1)
Norway (1) · Turkey (Türkiye) (1) · United States (1)
Jan T Gran, Professor (1) · Yihong Yao, PhD (1)